Dylan Zylla

7PUBLICATIONS
33CO-AUTHORS
Taxation lawEpidemiological modellingChemotherapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 05, 2026
Letter: The Difficulty in Validating Cannabis Anticancer Claims.

|May 12, 2026
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39).

|Jan 09, 2026
Pilot Randomized Trial of Medical Cannabis to Reduce Symptom Burden in Patients With Newly Diagnosed Advanced Pancreatic Cancer (CanPan).

Dylan Zylla, Ella Chrenka, Kendall Lin

|Apr 21, 2022
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).

Neeraj Agarwal, Catherine M Tangen, Maha H A Hussain

|Aug 09, 2021
Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports.

Jordan Guggisberg, Megan Schumacher, Grace Gilmore

|Nov 09, 2019
Collection of electronic patient-reported symptoms in patients with advanced cancer using Epic MyChart surveys.

Dylan M Zylla, Grace E Gilmore, Grant L Steele

Pageof 2

Frequent Collaborators

1 joint publications

Allison M Deal

1 joint publications

Yashasvini Sampathkumar

1 joint publications

Gina L Mazza

1 joint publications

Deborah Schrag